Analytical Services
The development and validation of methods, the performance of release tests and complete stability tests are just some of our core competencies.
Our technical equipment allows us to storage pharmaceutical drugs at different climate zones.
Moreover, Umforana has the authorization for handling with narcotics according to § 3 BtMG and as a result we can also offer analyses of narcotics.
In addition to the analysis of Rx and OTC preparations, we also have extensive experience and the necessary safety precautions to be able to analyze cytostatics and hormones.
All analyses and documentation are performed in compliance with GMP standards and according to our customers’ specifications.
-
Method development and validation
One focus of our work is the development and validation of specific analytical methods for testing finished medicinal products and raw materials for the determination of assay, analysis of known and unknown impurities, as well as dissolutions from solid and semi-Solid dosage forms using various measurement techniques. If required, we can also optimize existing methods for you.
The method development is based on Pharmacopoeia and/ or suitable literature-methods and requires qualified specialists with many years of experience. In close cooperation with our customers, we adjust the chosen method to the requirements of their product.
Subsequently, these methods can be validated according to the European guideline ICH Q2 (R1) and according to customer requirements.
Validation parameters are defined individually. Characteristic parameters of methods are, for example:
- Specificity/ Selectivity
- Linearity
- Limit of quantification (LOQ) and Limit of detection (LOD)
- Working range
- Accuracy/ Recovery
- Precision/ Intermediate Precision
- Stabilities of solutions
- Robustness (influence of critical parameters, stability of solutions)
- Degradation study as part of the robustness for a purity method (stress conditions: photolytic, thermal, oxidative, acidic and alkaline stress as well as the influence of metal ions)
In addition to the analytical part, we also create a validation plan based on the specifications of the customer and/or the authorities. Our experience of regulatory requirements covers not only the European market, but also the Japanese and Brazilian markets. After the plan has been approved by both parties, the analysis is carried out and finally we create the validation report.
A comprehensive validation report with all validation data in German or English rounds off our offer. This means that the results can be tracked at any time. - Method transfer and verification
- Stability studies
- Quality control of raw materials and finished pharmaceutical products
- Dissolution
Active ingredient list
-
- ACC
- Acetylsalicylsäure
- Aciclovir
- Aescin
- Aflatoxine
- Ambroxol
- Amilorid
- Aminosäuren
- Amiodaron
- Amitriptylin
- Amoxicillin
- Ampicillin
- Arnika-Tinktur
- Atenolol
- Azathioprin
- Azithromycin -
- Benzathin
- Benzethoniumchlorid
- Benzocain
- Benzbromaron
- Benzylalkohol
- Benzylpenicillin
- Bezafibrat
- Biotin
- Bisoprololfumarat
- Bromazepam
- Bromocriptin
- Budesonid
- Bufexamac
- Buflomedil
- Buspiron
- Butylhydroxyanisol
- Butylhydroxybenzoat -
- Calciumpanthothenat
- Campher
- Captopril
- Captopril/HCT
- Carbamazepin
- Carbidopa
- Carboplatin
- Carotin
- Cefixim
- Cefradoxil
- Ceftriaxon
- Cefuroxim-Na
- Cetirizin
- Chlorobutanol
- Chlorpromazin
- Clobetasol
- Clindamycin-HCl
- Clobetasol
- Clomifencitrat
- Clotrimazol
- Clozapin
- Colestyramin
- Crokonazol
- Cromoglycinsäure
- Cyanocobalamin -
- Diazepam
- Diclofenac
- Diltiazem
- Dimethicon
- Dipyridamol
- Dobutamin
- Doxazosin
- Doxepin
- Doxicyclin
- Doxorubicin -
- Enalipril
- Epirubicin
- Erythromycin
- Erythromycinethylsuccinat
- Estramustinphosphat
- Ethylhydroxybenzoat
- Etoposid -
- Finasterid
- Fluconazol
- 5 Fluorouracil
- Fluoxetin
- Fluvoxaminmaleat
- Folsäure
- Fumarsäure
- Furosemid -
- Gemfibrozil
- Glibenclamid -
- Haloperidol
- Hexamidin
- Hydrochlorothiazid
- Hydroxocobalamin -
- Ibuprofen
- Iopamidol
- Indoramin
- Isosorbid
- Isosorbid-5-mononitrat
- Isosorbiddinitrat
- Isotretion -
-
- Ketamin
- Ketotifen -
- Lactulose
- Leuprorelin
- Levamisol
- Lincomycin-HCl
- Liponsäure
- Lisinopril
- Loperamid
- Lovastatin
- Lysolecithin -
- Maleinsäure
- Maprotilin
- Mefrusid
- Megestrolacetat
- Menthol
- Merdroxyprogesteronacetat
- Methioninsulfoxid
- Methotrexat
- Methylhydroxybenzoat
- Methylprednisolon
- Methylsalicylat
- Metoclopramid
- Metoprololtartrat
- Mianserin
- Milchsäure
- Minocyclin
- Mitomycin
- Mitoxanthron
- Molsidomin -
- Naltrexon
- Naproxen
- Nircadipin
- Nicotinsäurebenzylester
- Nicotinsäureisopropylester
- Nifedipin
- Nimodipin
- Norfloxacin
- Norgestrel -
- Omeprazol
- Ondansetron
- Oxomenazin
- Oxytetracyclin
- Oxytocin -
- Paracetamol
- Pentachlorphenol
- Pentoxifyllin
- Phenprocoumon
- Phenytoin
- Piperacilin
- Piperazin
- Piracetam
- Pirenzepin
- Piretanid
- Piroxycam
- Povidon Jod
- Propanolol
- Prednisolon
- Procain
- Propylhydroxybenzoat
- Pyridoxin -
-
- Ranitidin
- Riboflavinphosphat
- Rivano -
- Salbutamol
- Selegilin
- Sotalol
- Spironolacton
- Streptomycin
- Sulfachinoxalin
- Sulfadimidin
- Sulfamethoxazol
- Sulpirid -
- Tamoxifen
- Tarfenadin
- Testosteron
- Tetracain
- Thiamazol
- Ticlopidin
- Tocopherolacetat
- Tramadol
- Trimipramin
- Tylosin -
-
- Valproinsäure
- Verapamil -
-
-
-
- Zolpidemtatrat

Stability tests inclusive climate storage
Routine pharmaceutical analysis includes testing the release of solid dosage forms such as tablets and capsules in both fast-release and sustained-release form, as well as liquid preparations in the form of suspensions.